Literature DB >> 28032361

Relationship between Chlamydia trachomatis and Mycoplasma genitalium infection and pregnancy rate and outcome in Iranian infertile couples.

L Dehghan Marvast1, A Aflatoonian2, A R Talebi2, A Eley3, A A Pacey1.   

Abstract

The study was performed to investigate the prevalence of Chlamydia trachomatis and Mycoplasma genitalium in a population of infertile couples from Iran and how this relates to tubal factor infertility, pregnancy rate and outcome of pregnancy. Blood, semen and first-void urine samples were obtained from 250 infertile couples and 250 fertile women as a control. Infertile couples were followed up after 24 months to determine diagnosis, referral for assisted conception, any pregnancy and pregnancy outcome. Data were analysed with regard to the results of (i) serological analysis for specific antibodies to C. trachomatis in serum; (ii) the presence of C. trachomatis and M. genitaliumDNA in first-void urine; and (iii) in a semen sample of the male partner. Prevalence of C. trachomatis in our study population was comparable to other studies using similar methods and test specimens. No evidence of M. genitalium infection was found. Detection of C. trachomatis in one partner rarely correlated with infection in the other. The risk of tubal factor infertility and the probability of pregnancy and pregnancy outcome were unrelated to the results of serological tests for C. trachomatis antibodies or the presence of C. trachomatisDNA in first-void urine of both partners and in a semen sample provided by the male.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990Chlamydia trachomatiszzm321990; zzm321990Mycoplasma genitaliumzzm321990; zzm321990PCRzzm321990; Infertility; pregnancy outcome

Mesh:

Year:  2016        PMID: 28032361     DOI: 10.1111/and.12747

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  6 in total

1.  Chlamydia trachomatis neither exerts deleterious effects on spermatozoa nor impairs male fertility.

Authors:  Jenniffer Puerta Suarez; Leonardo R Sanchez; Florencia C Salazar; Hector A Saka; Rosa Molina; Andrea Tissera; Virginia E Rivero; Walter D Cardona Maya; Ruben D Motrich
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

Review 2.  Mesenchymal Stem-Cell Derived Exosome Therapy as a Potential Future Approach for Treatment of Male Infertility Caused by Chlamydia Infection.

Authors:  Mahin Izadi; Laleh Dehghan Marvast; Mohammad Ebrahim Rezvani; Marzieh Zohrabi; Ali Aliabadi; Seyed Alireza Mousavi; Behrouz Aflatoonian
Journal:  Front Microbiol       Date:  2022-01-13       Impact factor: 5.640

Review 3.  Potential of Mesenchymal Stem Cell-Derived Exosomes as a Novel Treatment for Female Infertility Caused by Bacterial Infections.

Authors:  Marzieh Zohrabi; Laleh Dehghan Marvast; Mahin Izadi; Seyed Alireza Mousavi; Behrouz Aflatoonian
Journal:  Front Microbiol       Date:  2022-01-27       Impact factor: 5.640

4.  Detection of urinary Chlamydia trachomatis, Mycoplasma genitalium and human papilloma virus in the first trimester of pregnancy by PCR method.

Authors:  Monireh Rahimkhani; A Mordadi; M Gilanpour
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-06-04       Impact factor: 3.944

5.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.

Authors:  Jane Rowley; Stephen Vander Hoorn; Eline Korenromp; Nicola Low; Magnus Unemo; Laith J Abu-Raddad; R Matthew Chico; Alex Smolak; Lori Newman; Sami Gottlieb; Soe Soe Thwin; Nathalie Broutet; Melanie M Taylor
Journal:  Bull World Health Organ       Date:  2019-06-06       Impact factor: 9.408

6.  Pregnancies and Time to Pregnancy in Women With and Without a Previous Chlamydia trachomatis Infection.

Authors:  Bernice M Hoenderboom; Jan E A M van Bergen; Nicole H T M Dukers-Muijrers; Hannelore M Götz; Christian J P A Hoebe; Henry J C de Vries; Ingrid V F van den Broek; Frank de Vries; Jolande A Land; Marianne A B van der Sande; Servaas A Morré; Birgit H B van Benthem
Journal:  Sex Transm Dis       Date:  2020-11       Impact factor: 3.868

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.